US Stocks
/
X4 Pharmaceuticals, Inc. Share Price

X4 Pharmaceuticals, Inc. Share Price

NASDAQ: XFOR | Micro Cap
$2.79
-$0.01 (-0.36%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

X4 Pharmaceuticals, Inc. Stock Performance

Open
$2.73
Prev. Close
$2.81
Circuit Range
N/A
Day Range
$2.71 - $2.81
Year Range
$2.71 - $4.82
Volume
26,206
Average Traded
$2.77

X4 Pharmaceuticals, Inc. Share Price Today

As of 9 October 2026, X4 Pharmaceuticals, Inc.'s share price is $2.79. The stock opened at $2.73, compared to its previous close of $2.81. During today's trading session, X4 Pharmaceuticals, Inc.'s share price traded between $2.71 and $2.81, with an average price of $2.75. Over the past 52 weeks, the stock has recorded a high of $4.82 and a low of $2.71. In terms of performance, X4 Pharmaceuticals, Inc.'s share price has declined by 31.50% over the last six months and is down 30.82% on a year-on-year basis.

X4 Pharmaceuticals, Inc. Share Price Chart

$2.71$2.81
L
Show Current Price
H

X4 Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$118.21M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.91
Revenue (TTM)
$35.11B
Return On Equity (TTM)
-57.98%
Profit Margin
-225.58%
Debt to Equity
0.49
Quarterly Earnings Growth YoY
45.81%

X4 Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1.77$2.57$2.71$8.81
Net Profit-$29.82-$23.93-$20.24-$16.16
Net Profit Margin-1684.75%-931.13%-746.86%-183.43%
Income ChangeN/A19.75%15.42%20.16%

X4 Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$2.56$35.11
Net Profit-$96.41-$101.17-$37.45-$79.20
Net Profit MarginN/AN/A-1462.89%-225.58%
Income ChangeN/A-4.94%62.98%-111.48%

About X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

X4 Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.87
$2.79
-3.79%
Sep 2026
$4.04
$2.90
-31.24%
Aug 2026
$4.00
$4.22
+6.42%
Jul 2026
$4.63
$3.97
-14.90%
Jun 2026
$4.20
$4.67
+8.36%
May 2026
$4.07
$4.30
+5.51%
Apr 2026
$4.23
$4.08
-0.97%
Mar 2026
$3.31
$4.12
+20.12%
Feb 2026
$3.67
$3.43
-7.30%
Jan 2026
$3.91
$3.70
-7.82%
Dec 2025
$3.58
$4.01
+9.97%
Nov 2025
$3.98
$3.65
-9.65%

XFOR Share Price FAQs

What is X4 Pharmaceuticals, Inc. share price today?

chevron-up
X4 Pharmaceuticals, Inc. share price today is $2.79 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of X4 Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of X4 Pharmaceuticals, Inc. stock is $4.82, while the 52 week low is $2.71 as of 9 Oct '26.

What is XFOR's market capitalisation today?

chevron-up
XFOR market capitalisation is $118.21M as of October 9, 2026, at 4:47 pm IST.

What is XFOR's net income for the last quarter?

chevron-up
XFOR's net income for the last quarter is -16.16B USD.

What is the 5 year returns of XFOR?

chevron-up
The 5 year returns of XFOR is -98.08% as on 9 Oct '26.

What is the high & low stock price of XFOR today?

chevron-up
XFOR stock price hit a high of $2.81 and low of $2.71 as of 9 Oct '26.

Can I buy XFOR shares in India?

chevron-up
Yes. You can buy XFOR in India by opening an international trading account.